FIRST TRUST ADVISORS LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,320,783
+627.3%
85,182
+493.9%
0.00%
Q2 2023$319,109
-62.4%
14,342
-63.4%
0.00%
-100.0%
Q1 2023$848,573
-71.8%
39,177
-73.5%
0.00%
-75.0%
Q4 2022$3,004,214
+60.0%
147,918
+101.9%
0.00%
+100.0%
Q3 2022$1,878,000
-18.8%
73,251
-24.7%
0.00%
-33.3%
Q2 2022$2,314,000
+13.3%
97,319
+7.3%
0.00%
+50.0%
Q1 2022$2,043,000
+110.4%
90,704
+85.0%
0.00%
+100.0%
Q4 2021$971,000
+217.3%
49,017
+214.8%
0.00%
Q3 2021$306,000
-83.6%
15,571
-81.7%
0.00%
-100.0%
Q2 2021$1,871,000
-63.0%
85,051
-59.9%
0.00%
-66.7%
Q1 2021$5,051,000
+97.5%
212,318
+117.2%
0.01%
+100.0%
Q4 2020$2,557,000
+2.1%
97,732
-32.1%
0.00%
-25.0%
Q3 2020$2,504,000
-6.6%
143,842
-9.7%
0.00%
-20.0%
Q2 2020$2,680,000
+287.8%
159,309
+174.3%
0.01%
+150.0%
Q1 2020$691,000
-76.9%
58,079
-76.5%
0.00%
-60.0%
Q4 2019$2,995,000
+329.1%
247,523
+401.1%
0.01%
+400.0%
Q3 2019$698,000
+409.5%
49,397
+301.7%
0.00%
Q2 2019$137,000
-93.0%
12,297
-92.6%
0.00%
-100.0%
Q1 2019$1,959,000
+83.6%
166,831
+119.2%
0.00%
+100.0%
Q3 2018$1,067,000
-7.9%
76,108
+3.3%
0.00%0.0%
Q2 2018$1,158,000
-45.9%
73,652
-43.4%
0.00%
-60.0%
Q1 2018$2,141,000
-20.1%
130,166
-12.2%
0.01%
-16.7%
Q4 2017$2,678,000
-32.6%
148,265
-28.0%
0.01%
-40.0%
Q3 2017$3,972,000
+60.0%
205,812
-2.2%
0.01%
+42.9%
Q2 2017$2,483,000210,4610.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders